MXPA00012852A - Metodo para el diagnostico temprano de carcinomas. - Google Patents
Metodo para el diagnostico temprano de carcinomas.Info
- Publication number
- MXPA00012852A MXPA00012852A MXPA00012852A MXPA00012852A MXPA00012852A MX PA00012852 A MXPA00012852 A MX PA00012852A MX PA00012852 A MXPA00012852 A MX PA00012852A MX PA00012852 A MXPA00012852 A MX PA00012852A MX PA00012852 A MXPA00012852 A MX PA00012852A
- Authority
- MX
- Mexico
- Prior art keywords
- carcinomas
- early diagnosis
- overexpression
- cell cycle
- comprises determining
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57411—Specifically defined cancers of cervix
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57423—Specifically defined cancers of lung
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19829473A DE19829473C2 (de) | 1998-07-01 | 1998-07-01 | Verfahren zur frühen Diagnose von Carcinomen |
| PCT/DE1999/002094 WO2000001845A2 (de) | 1998-07-01 | 1999-07-01 | Verfahren zur frühen diagnose von carcinomen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA00012852A true MXPA00012852A (es) | 2003-09-11 |
Family
ID=7872684
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA00012852A MXPA00012852A (es) | 1998-07-01 | 1999-07-01 | Metodo para el diagnostico temprano de carcinomas. |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US6709832B1 (es) |
| EP (1) | EP1092155B1 (es) |
| JP (1) | JP3404020B2 (es) |
| KR (1) | KR100646193B1 (es) |
| CN (1) | CN1209627C (es) |
| AT (1) | ATE230487T1 (es) |
| AU (1) | AU749769B2 (es) |
| BR (1) | BRPI9912227B8 (es) |
| CA (1) | CA2336153C (es) |
| CZ (1) | CZ292076B6 (es) |
| DE (2) | DE19829473C2 (es) |
| DK (1) | DK1092155T3 (es) |
| ES (1) | ES2190820T3 (es) |
| HK (1) | HK1038609A1 (es) |
| HU (1) | HUP0102744A2 (es) |
| IL (1) | IL140550A (es) |
| MX (1) | MXPA00012852A (es) |
| NO (1) | NO328685B1 (es) |
| PL (1) | PL198623B1 (es) |
| RU (1) | RU2217761C2 (es) |
| SK (1) | SK284056B6 (es) |
| TR (1) | TR200003903T2 (es) |
| WO (1) | WO2000001845A2 (es) |
Families Citing this family (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7306926B2 (en) * | 1998-07-01 | 2007-12-11 | Mtm Laboratories Ag | Method for detecting carcinomas in a solubilized cervical body sample |
| AUPP991199A0 (en) * | 1999-04-21 | 1999-05-13 | University Of Sydney, The | Methods for diagnosing pre-cancerous and cancerous conditions |
| DE10006033B4 (de) | 2000-02-10 | 2005-11-10 | Professor Dr. Magnus von Knebel Doeberitz Chirurgische Universitätsklinik Sektion für Molekulare Diagnostik und Therapie | Immunisierung eines Individuums gegen Carcinome und ihre Vorstufen |
| US9249229B2 (en) | 2000-12-08 | 2016-02-02 | Alexion Pharmaceuticals, Inc. | Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| US20060057651A1 (en) * | 2000-12-08 | 2006-03-16 | Bowdish Katherine S | Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| US7408041B2 (en) | 2000-12-08 | 2008-08-05 | Alexion Pharmaceuticals, Inc. | Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| AUPR201500A0 (en) * | 2000-12-11 | 2001-01-11 | Biosceptre Pty Ltd | Methods for identifying pre-neoplastic and neoplastic states in mammals |
| DE10063179A1 (de) * | 2000-12-18 | 2002-06-20 | Bayer Ag | Verfahren zur spezifischen Detektion von Tumorzellen und ihren Vorstufen in Gebärmutterhalsabstrichen durch simultane Messung von mindestens zwei verschiedenen molekularen Markern |
| DK1961767T3 (da) * | 2001-01-17 | 2012-05-29 | Biosceptre Int Ltd | Diagnose og behandling af cancere og andre lidelser |
| EP1369694A1 (en) * | 2002-04-09 | 2003-12-10 | MTM Laboratories AG | Method for discrimination of metaplasias from neoplastic or preneoplastic lesions |
| ATE261126T1 (de) * | 2002-08-01 | 2004-03-15 | Mtm Lab Ag | Verfahren für lösung-basierte diagnose |
| EP1422526A1 (en) | 2002-10-28 | 2004-05-26 | MTM Laboratories AG | Method for improved diagnosis of dysplasias |
| WO2004070062A2 (en) * | 2003-02-04 | 2004-08-19 | Wyeth | Compositions and methods for diagnosing and treating cancers |
| JP4317188B2 (ja) * | 2003-02-26 | 2009-08-19 | シスメックス株式会社 | 細胞の検査方法 |
| ATE289685T1 (de) * | 2003-08-25 | 2005-03-15 | Mtm Lab Ag | Verfahren zum nachweis von karzinomen in solubilisierten zervikalen körperproben |
| KR100882249B1 (ko) * | 2004-03-24 | 2009-02-06 | 트리패스 이미징, 인코포레이티드 | 자궁경부 질환의 검사 방법 및 조성물 |
| US8921057B2 (en) | 2004-05-31 | 2014-12-30 | Sysmex Corporation | Method of assessing properties of mammalian cells, and method of diagnosing cancer using the same |
| EP1628135A1 (en) * | 2004-08-20 | 2006-02-22 | MTM Laboratories AG | Method for detecting medically relevant conditions in a solubilized LBC sample |
| US7892750B1 (en) * | 2004-12-23 | 2011-02-22 | University Of Notre Dame Du Lac | Cathepsin E as a marker of colon cancer |
| JP4766969B2 (ja) | 2005-09-14 | 2011-09-07 | シスメックス株式会社 | 組織性質判定装置 |
| US7972776B2 (en) * | 2005-11-15 | 2011-07-05 | Oncohealth Corporation | Protein chips for HPV detection |
| NZ599035A (en) | 2006-01-12 | 2013-12-20 | Alexion Pharma Inc | Antibodies to ox-2/cd200 and uses thereof |
| EP2082032A4 (en) * | 2006-10-10 | 2010-06-30 | Biosceptre Int Ltd | ANTIBODIES AGAINST NON-FUNCTIONAL P2X7 RECEPTOR PRODUCING HYBRIDOMES |
| US8865162B2 (en) | 2008-06-13 | 2014-10-21 | Oncohealth Corp. | Monoclonal antibodies against HPV proteins |
| US8968995B2 (en) * | 2008-11-12 | 2015-03-03 | Oncohealth Corp. | Detection, screening, and diagnosis of HPV-associated cancers |
| JP5111902B2 (ja) * | 2007-03-14 | 2013-01-09 | シスメックス株式会社 | 癌の診断支援装置 |
| US8921114B2 (en) | 2007-08-24 | 2014-12-30 | Sysmex Corporation | Diagnosis support system for cancer, diagnosis support information providing method for cancer, and computer program product |
| NZ583896A (en) | 2007-09-14 | 2011-05-27 | Biosceptre Int Ltd | Purinergic (p2x) receptors in extra-cellular body fluid |
| CA2737126C (en) | 2007-09-14 | 2018-05-01 | Biosceptre International Limited | Novel p2x7 epitopes |
| CN102143978B (zh) * | 2008-07-04 | 2015-02-18 | 生物权威国际有限公司 | 抗p2x7肽和表位 |
| JP2012526286A (ja) * | 2009-05-07 | 2012-10-25 | オンコヘルス コーポレーション | ヒトパピローマウイルス（ｈｐｖ）およびｈｐｖ関連癌の初期段階および後期段階の検出、スクリーニング、および診断のための高度または≧ｃｉｎ２の同定 |
| WO2011020155A1 (en) | 2009-08-20 | 2011-02-24 | Biosceptre International Limited | Anti p2x7 receptor antibodies and fragments thereof |
| WO2011075789A1 (en) | 2009-12-24 | 2011-06-30 | Biosceptre International Limited | Antibodies to non-functional oligomeric p2x7 receptors |
| WO2011084598A1 (en) | 2010-01-08 | 2011-07-14 | Oncohealth Corporation | High throughput cell-based hpv immunoassays for diagnosis and screening of hpv-associated cancers |
| US8900813B2 (en) | 2010-08-17 | 2014-12-02 | Medical Diagnostic Laboratories, Llc | CIP2A as a biomarker in detection of cervical cancer |
| WO2012031333A1 (en) | 2010-09-10 | 2012-03-15 | Biosceptre International Limited | Companion animal treatments |
| US9551700B2 (en) | 2010-12-20 | 2017-01-24 | Milagen, Inc. | Device and methods for the detection of cervical disease |
| CN103702683B (zh) | 2011-07-01 | 2017-07-04 | 生物权威(澳大利亚)有限责任公司 | 联合治疗 |
| US10527526B2 (en) | 2011-11-03 | 2020-01-07 | Tripath Imaging, Inc. | Methods and compositions for preparing samples for immunostaining |
| BR112014011563B1 (pt) * | 2011-11-15 | 2022-05-24 | University Of Miami | Método para determinar um risco aumentado de carcinoma de células escamosas de cabeça e pescoço (hnscc) em um indivíduo humano infectado com papiloma vírus humano (hpv), e kit |
| WO2019067499A1 (en) | 2017-09-27 | 2019-04-04 | Alexion Pharmaceuticals, Inc. | BIOMARKER SIGNATURE FOR PREDICTING A TUMOR RESPONSE TO ANTI-CD200 THERAPY |
| WO2019234176A1 (en) | 2018-06-07 | 2019-12-12 | Universitaet Des Saarlandes | Novel biomarkers for carcinoma diagnosis |
| CN108893534A (zh) * | 2018-06-26 | 2018-11-27 | 华中科技大学鄂州工业技术研究院 | 泛癌症诊断标记物 |
| RU2707884C1 (ru) * | 2018-10-03 | 2019-12-02 | федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский университет) (ФГАОУ ВО Первый МГМУ им. И.М. Сеченова Минздрава России (Се | Способ ранней диагностики почечно-клеточной карциномы по наличию антител к зрительному аррестину |
| FR3088640A1 (fr) | 2018-10-14 | 2020-05-22 | Smart Diagnostix Pharma | Nouveau polypeptide se liant specifiquement a la proteine p16 |
| CN111257565A (zh) * | 2018-12-03 | 2020-06-09 | 上海细胞治疗集团有限公司 | 一种衰老细胞的检测试剂盒及其检测方法 |
| CN113295683A (zh) * | 2021-05-24 | 2021-08-24 | 烟台海关技术中心 | 过氧化苯甲酰检测方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4281061A (en) * | 1979-07-27 | 1981-07-28 | Syva Company | Double antibody for enhanced sensitivity in immunoassay |
| US5268463A (en) * | 1986-11-11 | 1993-12-07 | Jefferson Richard A | Plant promoter α-glucuronidase gene construct |
| ES2201064T3 (es) | 1992-10-16 | 2004-03-16 | Cold Spring Harbor Laboratory | Transposicion del complejo de ciclina y usos relacionados del mismo. |
| AU5694694A (en) * | 1992-12-02 | 1994-06-22 | Denis F. Hochstrasser | A method for detecting growing cells using translationally controlled tumor protein p21 |
| US5543291A (en) * | 1993-01-29 | 1996-08-06 | Dana Farber Cancer Institute | Method of detecting carcinoma |
| US6316208B1 (en) * | 1994-01-07 | 2001-11-13 | Memorial Sloan-Kettering Cancer Center | Methods for determining isolated p27 protein levels and uses thereof |
| JPH08510391A (ja) * | 1994-03-18 | 1996-11-05 | ユニバーシティ・オブ・ユタ・リサーチ・ファウンデーション | Ｍｔｓ遺伝子における生殖系統の変異およびｍｔｓ遺伝子における癌の素因の検出方法 |
| US5763190A (en) * | 1994-09-21 | 1998-06-09 | The Trustees Of The University Of Pennsylvania | Methods for the identification of compounds capable of inducing the nuclear translocation of a receptor complex comprising the glucocoticoid receptor type II and viral protein R interacting protein |
| US6033847A (en) * | 1995-02-06 | 2000-03-07 | St. Jude Children's Research Hospital | InK4c-p18 and InK4d-p19, inhibitors of cyclin-dependent kinases CDK4 and CDK6, and uses thereof |
| US5976799A (en) | 1996-03-21 | 1999-11-02 | The Board Of Trustees Of The University Of Arkansas | Early detection of ovarian carcinoma using P16 gene products |
| US5851797A (en) * | 1996-06-19 | 1998-12-22 | Regeneron Pharmaceuticals, Inc. | Tie ligand-3, methods of making and uses thereof |
| US5858683A (en) * | 1996-08-30 | 1999-01-12 | Matritech, Inc. | Methods and compositions for the detection of cervical cancer |
| WO2000024245A1 (en) * | 1998-10-28 | 2000-05-04 | President And Fellows Of Harvard College | REGULATION OF TH2 CELL ACTIVITY BY MODULATION OF NFATp AND NFAT4 ACTIVITY |
-
1998
- 1998-07-01 DE DE19829473A patent/DE19829473C2/de not_active Expired - Lifetime
-
1999
- 1999-07-01 JP JP2000558235A patent/JP3404020B2/ja not_active Expired - Lifetime
- 1999-07-01 MX MXPA00012852A patent/MXPA00012852A/es active IP Right Grant
- 1999-07-01 PL PL345407A patent/PL198623B1/pl unknown
- 1999-07-01 BR BRPI9912227 patent/BRPI9912227B8/pt active IP Right Grant
- 1999-07-01 HU HU0102744A patent/HUP0102744A2/hu unknown
- 1999-07-01 WO PCT/DE1999/002094 patent/WO2000001845A2/de active IP Right Grant
- 1999-07-01 CA CA002336153A patent/CA2336153C/en not_active Expired - Lifetime
- 1999-07-01 AU AU58487/99A patent/AU749769B2/en not_active Expired
- 1999-07-01 CN CNB998079111A patent/CN1209627C/zh not_active Expired - Lifetime
- 1999-07-01 AT AT99945931T patent/ATE230487T1/de active
- 1999-07-01 RU RU2001102598/15A patent/RU2217761C2/ru active
- 1999-07-01 DK DK99945931T patent/DK1092155T3/da active
- 1999-07-01 ES ES99945931T patent/ES2190820T3/es not_active Expired - Lifetime
- 1999-07-01 KR KR1020017000026A patent/KR100646193B1/ko not_active IP Right Cessation
- 1999-07-01 US US09/743,103 patent/US6709832B1/en not_active Expired - Lifetime
- 1999-07-01 EP EP99945931A patent/EP1092155B1/de not_active Expired - Lifetime
- 1999-07-01 DE DE59903915T patent/DE59903915D1/de not_active Expired - Lifetime
- 1999-07-01 TR TR2000/03903T patent/TR200003903T2/xx unknown
- 1999-07-01 CZ CZ20004922A patent/CZ292076B6/cs not_active IP Right Cessation
- 1999-07-01 SK SK2031-2000A patent/SK284056B6/sk not_active IP Right Cessation
- 1999-07-01 IL IL14055099A patent/IL140550A/xx not_active IP Right Cessation
-
2000
- 2000-12-28 NO NO20006681A patent/NO328685B1/no not_active IP Right Cessation
-
2001
- 2001-10-18 HK HK01107321A patent/HK1038609A1/xx not_active IP Right Cessation
-
2003
- 2003-02-20 US US10/371,883 patent/US20030152993A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1038609A1 (en) | Method for early diagnosis of carcinomas | |
| HK1092219A1 (en) | Method for detecting neoplastic disorders in a solubilized body sample | |
| WO2000005265A3 (en) | Anti-crr2 antibodies and methods of use therefor | |
| MY138674A (en) | Radiolabeling kit and binding assay | |
| EP1687283A4 (en) | PROCESS AND COMPOSITION FOR DETERMINING FK 506 | |
| EP1102988B8 (de) | Verfahren zur bestimmung der immunabwehraktivität des blutes sowie testkit hierfür | |
| WO1997008318A3 (en) | Compounds and methods for treatment and diagnosis of prostate cancer | |
| EP1708745A4 (en) | ANTIBODIES FOR ONCOGEN STRAINS OF HPV AND METHODS OF USE | |
| WO2000035950A3 (en) | Reagents and methods useful for detecting diseases of the breast | |
| SE9604815D0 (sv) | A metod of diagnosis | |
| AU7336400A (en) | Diagnostic assay for type 2 heparin-induced thrombocytopenia | |
| WO2002021133A3 (en) | Methods of detecting cancer based on prostasin | |
| HK1044190A1 (en) | A method for identifying pre-neoplastic and/or neoplastic states in mammals | |
| AU7571998A (en) | Rapid evaluation of the ratio of biological molecules | |
| WO2001007471A3 (en) | Cell cycle and proliferation proteins | |
| GB0004576D0 (en) | Proteins | |
| AU4865997A (en) | Monoclonal antibodies against a human act and serine protease complex | |
| SE0002835D0 (sv) | Method and kit for production of monoclonal antibodies | |
| AU4908799A (en) | Determination of the hydrophobic pulmonary surfactant protein sp-c | |
| AU2002233278A1 (en) | Method and use of the cytosolic nadp-dependent malate-decarboxylase isoenzyme for identifying a malignant process, and a suitable test kit | |
| AU9437598A (en) | Method and kit for identifying interactions between proteins or peptides | |
| EP1191096A4 (en) | NEW PROTEIN AND ITS DNA | |
| NO992531L (no) | Fremgangsmåter ved fremstilling av rekombinant protein | |
| AU4459197A (en) | Diagnosis aid and process for detecting pregnancy in ruminants | |
| EP1702984A3 (en) | A method for detecting prostate cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |